estrogel 0,6 mg/g
besins healthcare ireland limited - estradiol - gel - 0,6 mg/g
testogel 50 mg/dosis transdermal gel
laboratoires besins int. s.a.s. - testosteron - transdermal gel - 50 mg/dosis
testogel 16,2 mg/g transdermal gel
laboratoires besins int. s.a.s. - testosteron - transdermal gel - 16,2 mg/g
duavive
pfizer europe ma eeig - østrogener konjugeret, bazedoxifene - menopausen - konjugerede østrogener og bazedoxifene - duavive er indiceret til:behandling af østrogen mangel symptomer hos postmenopausale kvinder med uterus (med mindst 12 måneder siden sidste menstruation), for hvem behandling med gestagen, der indeholder terapi er ikke passende. den erfaring med behandling af kvinder over 65 år er begrænset.
testogel 50 mg/dosis transdermal gel
orifarm a/s - testosteron - transdermal gel - 50 mg/dosis
norethisteron/estrogen "2care4" 0,5 + 1 mg tabletter
2care4 aps - estradiolvalerat, norethisteronacetat - tabletter - 0,5 + 1 mg
testogel 40,5 mg transdermal gel i brev
laboratoires besins int. s.a.s. - testosteron - transdermal gel i brev - 40,5 mg
testogel 16,2 mg/g transdermal gel
2care4 aps - testosteron - transdermal gel - 16,2 mg/g
testogel 25 mg/dosis transdermal gel
laboratoires besins int. s.a.s. - testosteronenantat - transdermal gel - 25 mg/dosis
faslodex
astrazeneca ab - fulvestrant - bryst neoplasmer - endokrine terapi, anti-østrogener - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. i præ - eller perimenopausal kvinder, kombinationen behandling med palbociclib bør kombineres med en luteiniserende hormon releasing hormon (lhrh) agonist.